About the use in nuclear medicine of pharmaceuticals on the basis of the isotope ¹⁸F and its achievements on linear electron accelerators of NIK "Accelerator"

• Published in: Вопросы атомной науки и техники
• Date: 2017
• ISSN: 1562-6016
• Main Authors: Azarov, A.I., Dovbnya, A.N., Dolzhec, M.A., Kushnir, V.A., Mitrochenko, V.V., Perezhogin, S.A., Selivanov, L.I., Tereshchenko, V.A., Titov, V.Yu., Titov, D.V., Shevchenko, V.A., Shramenko, B.I.
• Format: Article
• Language: English
• Published: Національний науковий центр «Харківський фізико-технічний інститут» НАН України 2017
• Subjects: Применение ядерных методов
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/136189
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: About the use in nuclear medicine of pharmaceuticals on the basis of the isotope ¹⁸F and its achievements on linear electron accelerators of NIK "Accelerator" / A.I. Azarov, A.N. Dovbnya, M.A. Dolzhec, V.A. Kushnir, V.V. Mitrochenko, S.A. Perezhogin, L.I. Selivanov, V.A. Tereshchenko, V.Yu. Titov, D.V. Titov, V.A. Shevchenko, B.I. Shramenko // Вопросы атомной науки и техники. — 2017. — № 6. — С. 133-136. — Бібліогр.: 1 назв. — англ.

The importance widely used in the world of Radiopharmaceutical: 2-fluoro [¹⁸F]-2-deoxy-D-glucose (fluo-rideglucose, ¹⁸F) for the diagnosis of various diseases using PET and CT imaging are shown. Provides information about the levels of specific activity of aqueous solutions containing the isotope ¹⁸...